leadf
logo-loader
viewLexaGene Holdings Inc.

LexaGene prepares for commercialization of their newly named device MiQLab

LexaGene Holdings (CVE: LXG-OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company has announced the name and look of their new genetic analyzers for rapid pathogen detection. It’s called MiQLab 

Regan told Proactive why that name when they plan on having the units available on the market.

Quick facts: LexaGene Holdings Inc.

Price: 0.82 CAD

TSX-V:LXG
Market: TSX-V
Market Cap: $93.24 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of LexaGene Holdings Inc. named herein, including the promotion by the Company of LexaGene Holdings Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

LexaGene hires two salespeople to tackle diagnostic and vet market with new...

LexaGene (CVE: LXG-OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company has made two key sales hires as they look to begin to roll out their genetic analyzers for rapid pathogen detection called MiQLab. Regan says they are hiring in the...

on 14/7/20

2 min read